Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Nobel Prize awarded for enzyme research
Frances H. Arnold, George P. Smith and Sir Gregory Winter, 2018 Nobel Laureates in Chemistry.

Three scientists share 2018 Nobel Prize in Chemistry

The Nobel Prize in Chemistry 2018 has been awarded to three scientists for their research into enzymes.

Frances H. Arnold from the California Institute of Technology will share the award with George P. Smith, University of Missouri, and Sir Gregory P Winter from the MRC Laboratory of Molecular Biology, Cambridge.

In 1993, Frances Arnold became the first person to use a technique called ‘directed evolution’ to create new enzymes. Since then, she has refined the methods that are now routinely used to develop new catalysts.

The use of Frances Arnold’s enzymes include more environmentally friendly manufacturing of chemical substances and the production of renewable fuels.

George Smith received the award for developing a method known as phage display. This is where a bacteriophage - a virus that infects bacteria can be used to evolve new proteins. Sir Gregory Winter then used this method for the directed evolution of antibodies, with the aim of producing new pharmaceuticals.

The first pharmaceutical based on this method, adalimumab, was approved in 2002 and is used to treat rheumatoid arthritis, psoriasis and inflammatory bowel diseases. Phage display has since produced pharmaceuticals that can neutralise toxins, counteract autoimmune diseases and cure metastatic cancer.

Professor Dame Carol Robinson, Royal Society of Chemistry president, said: “Today’s Nobel Prize in chemistry highlights the tremendous role of chemistry in contributing to many areas of our lives including pharmaceuticals, detergents, green catalysis and biofuels. It is a great advert for chemistry to have impact in so many areas.

“Directed evolution of enzymes and antibody technology are subjects that I have followed with keen interest; both are now transforming medicine. It would have been hard to predict the outcome of this research at the start – this speaks to the need for basic research.

“I am delighted to see these areas of chemistry recognised and congratulate all three Nobel Laureates.”

Illustration: Niklas Elmehed. Copyright: Nobel Media AB 2018

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.